AOD-9604

Lipolytic GH fragment analogue that was not approved as an obesity drug.

What it does / how it works

The same GH tail with an extra tyrosine. Designed as a fat-loss fragment that would not act like full GH. Never approved as an obesity drug.

Class Tyr-hGH(177–191)
Typical vial 5 or 10 mg
Reconstitution 2 mL BAC per 5 mg = 2.5 mg/mL (300 mcg = 12 units)
Storage after mix 2–8°C, use within 28 days

Protocol

Goal Dose How often How long Route
Weeks 1-12 300 mcg Once daily fasted 8-12 weeks SubQ
Upper 500 mcg Once daily fasted 8-12 weeks SubQ
Off None Stop 4 weeks off –

Watch: Not a substitute for a GLP-1 protocol.

AOD-9604 FAQ — Australia

AOD-9604 was developed as a lipolytic fragment of HGH that would not raise IGF-1. Mid-2000s clinical development did not produce an approved obesity drug. Distinct from HGH Fragment 176–191 (ELV8 FR5).

Recommended Supplier — AOD-9604 Australia

Our products offer premium-grade research materials with independent testing at a leading Australian university. Every batch is strictly verified by RP-HPLC and LC-MS. For research purposes only.

Related Research — Australia

Explore similar research-grade peptides, selected to complement your research needs.

Tesamorelin + Ipamorelin

Tesamorelin target is 1-2 mg daily. Ipamorelin target....

Super Human Blend

One serving: L-Arginine 110 mg, L-Ornithine 110 mg,....

Semax + Selank

Short course. Intranasal preferred. Then 2-4 weeks off.....

Retatrutide + Cagrilintide

5+5 mg is a late stock, not a....
Select your currency
AUD Australian dollar